A. Shupak et al., CINNARIZINE IN THE PROPHYLAXIS OF SEASICKNESS - LABORATORY VESTIBULAREVALUATION AND SEA STUDY, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 670-680
Cinnarizine was evaluated for the prevention of seasickness in a labor
atory and sea study. The effects of 25 mg cinnarizine on the vestibule
-ocular reflex were investigated in 13 subjects. Significant reduction
of the gain in response to sinusoidal oscillations at 0.02, 0.08, and
0.16 Hz (p < 0.05) and increased phase lead at 0.16 Hz (p < 0.01) wer
e observed. The effect of 25 and 50 mg cinnarizine on seasickness seve
rity was examined in 95 subjects during a voyage in rough seas. Seasic
kness symptoms were improved in 69% of the subjects by 50 mg cinnarizi
ne versus 35% and 31% in the groups receiving 25 mg cinnarizine and pl
acebo (p < 0.05 and p < 0.01, respectively). The percentage of vomitin
g protection provided by 50 mg cinnarizine was 63% (p < 0.05). We conc
lude that 50 mg cinnarizine is an effective drug for the prevention of
seasickness. The reduction in vestibular sensitivity observed even af
ter administration of 25 mg cinnarizine may explain the potency of cin
narizine in the prevention of seasickness.